orvepitant(579475-18-6)
- Name: orvepitant
- Synonyms:GW 823296X;Orvepitant;
- Molecular Formula:C31H35F7N4O2
- Molecular Weight:628.633
- CAS Registry Number:579475-18-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.579475-18-6 orvepitant
Assay:97% Appearance:white to light yellow crystal powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] 
Premium
SupplierTel:1-631-485-4226
Address:Ramsey Road
- Contact Suppliers
Other Product
- 496054-87-6/1-Piperidineacetamide, N-(2,3-dihydro-2-oxo-6-benzoxazolyl)-4-[(4-fluorophenyl)methyl]-α-oxo-
- 787548-03-2/5'-Adenylic acid, N-[(ethylamino)carbonyl]-2',3'-O-[(1S,2E)-3-phenyl-2-propen-1-ylidene]-
- 522664-63-7/Benzo[b]thiophene-2-carboxamide, 6-methyl-N-[1-[[[(1R)-2-oxo-1-(phenylmethyl)-2-[[[1-[(tetrahydro-2H-pyran-4-yl)methyl]-4-piperidinyl]methyl]amino]ethyl]amino]carbonyl]cyclopentyl]-
- 405159-59-3/α-D-Glucopyranoside, methyl O-2-deoxy-2-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]amino]-3,4-di-O-methyl-6-O-sulfo-α-D-glucopyranosyl-(1→4)-O-2,3-di-O-methyl-β-D-glucopyranuronosyl-(1→4)-O-2,3,6-tri-O-sulfo-α-D-glucopyranosyl-(1→4)-O-2,3-di-O-methyl-α-L-idopyranuronosyl-(1→4)-, 2,3,6-tris(hydrogen sulfate), nonasodium salt (9CI)
- 188181-42-2/5'-O-(Elaidoyl) 1-β-D-arabinofuranosylcytosine
- 189059-71-0/Lapaquistat
- 335619-18-6/INAKALANT
- 207623-20-9/DNA, d(P-thio)(T-C-G-T-C-G-T-T-T-T-G-T-C-G-T-T-T-T-G-T-C-G-T-T)
- 870524-46-2/DNA (synthetic plasmid p3kDRαHPV16-18)
- 627861-07-8/Beperminogene perplasmid (9CI)
- 769901-96-4/1,3,4-Oxadiazol-2(3H)-one, 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-[1-(2-phenylethyl)-4-piperidinyl]-
- 872847-66-0/DNA, d(P-thio)(C-C-C-T-G-C-T-C-C-C-C-C-C-T-G-G-C-T-C-C), nonadecasodium salt (9CI)
- 544417-40-5/CAPADENOSON
- 338990-84-4/1-[3(R)-[4-(4-Cyanophenyl)thiazol-2-yl]-2(R)-(2,5-difluorophenyl)-2-hydroxybutyl]-4-[1-[N-methyl-N-[3-[2-(methylammonio)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl]-1H-1,2,4-triazol-4-ium dichloride
- 355151-12-1/Glycinamide, N-acetyl-D-tyrosyl-D-prolyl-(4S)-4-hydroxy-D-prolylglycyl-D-alanyl-
- 497221-38-2/L-Valinamide, L-alanylglycyl-L-tyrosyl-L-lysyl-L-prolyl-L-α-aspartyl-L-α-glutamylglycyl-L-lysyl-L-arginylglycyl-L-α-aspartyl-L-alanyl-L-cysteinyl-L-α-glutamylglycyl-L-α-aspartyl-L-serylglycylglycyl-L-prolyl-L-phenylalanyl-
- 872178-65-9/Rob 803
- 625114-41-2/Benzeneacetamide, 3-chloro-4-(methylsulfonyl)-α-[[(1R)-3-oxocyclopentyl]methyl]-N-2-pyrazinyl-, (αR)-
- 552292-08-7/Rolapitant
- 579475-18-6/orvepitant
- 481629-87-2/1H-Indole-3-acetic acid, 1-[[4-(1,1-dimethylethyl)phenyl]methyl]-5-(3-methylphenyl)-α-oxo-
- 318498-76-9/(3R,4R,5E,10E,12E,14S,16R,26aR)-16-Fluoro-14-hydroxy-3-isopropyl-4,12-dimethyl-3,4,8,9,14,15,16,17,24,25,26,26a-dodecahydro-7H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,22-trione
- 325965-23-9/5-[(2S)-1,2,3,6-Tetrahydro-5-(4-morpholinylmethyl)-2-pyridinecarboxylic acid]pristinamycin IA
- 442201-24-3/ReMogliflozin etabonate
- 677017-23-1/WP 769
- 187852-63-7/Glycinamide, glycylglycyl-N-[3-[[(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy]propyl]-, compd. with dextran carboxymethyl ether sodium salt
- 9007-72-1/Injectafer
- 211254-73-8/LONAPRISAN
- 218949-48-5/Tesamorelin (usan)
- 172740-14-6/5-Heptenoic acid, 7-[(1R,2S)-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-5-oxo-3-cyclopenten-1-yl]-, 1-methylethyl ester, (5Z)-